Peter Pisters: MD Anderson’s commitment to cell therapy discovery and patient care
Peter Pisters shared a post on LinkedIn:
“The Institute for Cell Therapy Discovery and Innovation is a key piece of MD Anderson Cancer Center’s institutional strategy.
Our clinicians and researchers have been instrumental in shaping the cell therapy field, and we are proud to take this important step to bring new treatments to our patients.”
Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine. He contributes to academic journals like the Journal of Clinical Oncology and Surgery, and reviews for various publications. His research, concentrated on sarcomas, GI cancers, and other malignancies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023